Tau protein in normal and Alzheimer's disease brain: an update.
about
A chemical with proven clinical safety rescues Down-syndrome-related phenotypes in through DYRK1A inhibitionGene expression profiles in anatomically and functionally distinct regions of the normal aged human brain.High-content siRNA screening of the kinome identifies kinases involved in Alzheimer's disease-related tau hyperphosphorylation.Mechanisms of tau-induced neurodegeneration.Sevoflurane induces tau phosphorylation and glycogen synthase kinase 3β activation in young miceGSK-3 activity is critical for the orientation of the cortical microtubules and the dorsoventral axis determination in zebrafish embryos.Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorialDeveloping pharmacological therapies for Alzheimer disease.Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention.Glycogen synthase kinase 3: a point of integration in Alzheimer's disease and a therapeutic target?Identification of disulfide cross-linked tau dimer responsible for tau propagationPresent and prospective clinical therapeutic regimens for Alzheimer's disease.The Alzheimer's disease mitochondrial cascade hypothesis: an updatePharmacotherapeutic targets in Alzheimer's diseaseRetinoic acid attenuates beta-amyloid deposition and rescues memory deficits in an Alzheimer's disease transgenic mouse model.The potential dual effects of sevoflurane on AKT/GSK3β signaling pathwayRecent advances in the design, synthesis, and biological evaluation of selective DYRK1A inhibitors: a new avenue for a disease modifying treatment of Alzheimer's?Cell-based Models To Investigate Tau Aggregation.Bilirubin as a determinant for altered neurogenesis, neuritogenesis, and synaptogenesis.Amyloid Beta and tau proteins as therapeutic targets for Alzheimer's disease treatment: rethinking the current strategy.A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer's Disease
P2860
Q28828212-20742708-9ACC-4DB8-B24F-008761B99CADQ33262303-5C33EF21-CA71-4B22-B93A-051F9EF923BCQ33523403-5B917DFA-1772-417D-996D-9755F9CAB678Q33859830-6006088F-D6EB-4C5F-9569-F54DE4F37213Q34195717-83EA1A58-0B52-40E3-A3FC-5008D81F0C4CQ34264873-A9CEEDFF-917F-4891-B31C-DB2C07F8224EQ34974083-2191C3E6-239E-4C6E-98DF-555232644D5DQ35114786-FBD3D932-CEC1-43CD-93C5-8388657CA0D7Q35114797-23F8C61E-08C7-4350-A443-34E5558ECADCQ36063447-D253951E-AFDC-4B8F-8C05-6723002DEEA4Q36164278-10926E0A-EBAE-4F16-8A32-A3A5C45396DFQ36876447-735D5475-5D00-4640-8324-2673DBE52A9AQ37261159-0F5414D3-518E-46EE-89F4-207A79FD9E95Q37295067-FCE1D1ED-7903-4CDD-BDAF-E159149D3AE8Q37352348-53B2B50A-B543-41E0-A1A8-85EDE114D237Q37717213-D0F0BC6E-D18A-487D-A644-1B61A990AFD9Q38061634-9A2D328E-2DB1-49D0-A934-ACB7ABEBA897Q38287992-873D8F5C-ABC3-4137-A7A4-87BE43F8AB09Q41848415-FC9BF4B6-5208-4703-8C7F-0351DF2E480DQ42281747-5C9FF201-A68C-45C9-9A20-EEB52510A3B5Q57927766-5AA46D75-7D83-4E7B-8DD5-9EC933345144
P2860
Tau protein in normal and Alzheimer's disease brain: an update.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Tau protein in normal and Alzheimer's disease brain: an update.
@ast
Tau protein in normal and Alzheimer's disease brain: an update.
@en
Tau protein in normal and Alzheimer's disease brain: an update.
@nl
type
label
Tau protein in normal and Alzheimer's disease brain: an update.
@ast
Tau protein in normal and Alzheimer's disease brain: an update.
@en
Tau protein in normal and Alzheimer's disease brain: an update.
@nl
prefLabel
Tau protein in normal and Alzheimer's disease brain: an update.
@ast
Tau protein in normal and Alzheimer's disease brain: an update.
@en
Tau protein in normal and Alzheimer's disease brain: an update.
@nl
P1476
Tau protein in normal and Alzheimer's disease brain: an update.
@en
P2093
Hartigan JA
Johnson GV
P304
P577
1999-11-01T00:00:00Z